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Bystind the effects of ischemia/reperfusion and chemical hypoxia on the morphology,
cell viability and expression of bystin and glial ﬁbrillary acidic protein (GFAP) in primary cultured astrocytes
which were prepared by the subculture method. The astrocytes in Hank's medium without glucose and
serum (oxygen–glucose deprivation, ischemic cells) were ﬁrst exposed to 1% O2 and then to 21% O2
(normoxia), or treated with different concentrations of CoCl2 or NaN3 for different periods. Relevant
observations and measurements were then conducted. The ﬁndings showed that treatment with 1% O2 for
0.5 or 3 h could induce a characteristic ‘reactive’ morphology and a signiﬁcant increase in cell viability and
total protein amount. The western blot analysis showed that treatment with 1% O2 for 0.5 or 3 h also induced
a signiﬁcant increase in the expression of bystin and that the response of bystin to mild ischemia was much
more sensitive than that of GFAP. Similar results were also found in the cells treated with mild chemical
hypoxia. The data demonstrated for the ﬁrst time that mild ischemia and hypoxia could activate astrocytes
and that bystin is a much more sensitive marker in activated astrocytes induced by ischemia and hypoxia as
compared to GFAP. The signiﬁcant up-regulation of bystin suggests that bystin may play an important role in
the activation of astrocytes as well as in the neuroprotective role of hypoxic and ischemic preconditioning.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionIt is well known that astrocytes have the critical functions of the
maintenance of ionic homeostasis, prevention of excitotoxicity,
scavenging free radicals, provision of nutrients and growth factors,
promotion of neovascularization, and support of synaptogenesis and
neurogenesis that may potentially inﬂuence the outcome of ischemic
injury [1]. Astrocytes become reactive (Astrogliosis) in response to
many pathologies of the central nervous system (CNS), such as stroke,
trauma, growth of a tumor, chemical insult or neurodegenerative
disease [2,3]. Astrogliosis is characterized by astrocyte proliferation,
extensive hypertrophy of nuclei, cell body, and cytoplasmic processes
and an increase in immunodetectable glial ﬁbrillary acidic protein
(GFAP) [4,5].
As a member of the cytoskeletal protein family, it is believed that
GFAP is important in modulating astrocytic motility and shape by
providing structural stability to astrocytic processes [5]. In addition toculty ofMedicine, The Chinese
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ll rights reserved.the increased expression of GFAPwith the activation of astrocytes, it has
been recently reported that bystin, a protein potentially involved in
embryo implantation [6,7], is markedly up-regulated in the reactive
astrocytes of both 6-hydrodopamine-lesioned nigrostriatum and stab-
lesioned cerebral cortex of adult rats in vivo and in postnatal cortical
astrocytes treatedwith pro-inﬂammatorymediators lipopolysaccharide
and interleukin-1b in vitro [8]. It has been also suggested [8] that bystin
acts as a novel marker for reactive astrocytes in the adult rat brain
following injury and its expression may be involved in the differentia-
tion of reactive astrocytes during the inﬂammatory processes.
However, it is unknown whether the expression of bystin is also
increased in the reactive astrocytes induced by other pathologies such
as ischemia and hypoxia because it has been suggested that different
types of injury may induce different astrocyte responses [9]. It is also
unknown whether the increased expression of bystin is a common
characteristic of astrogliosis. In this study, we therefore investigated
the effects of ischemia and chemical hypoxia on the morphology, cell
ability and expression of bystin as well as GFAP in primary cultured
astrocytes. Our ﬁndings demonstrated that compared with GFAP,
bystin is a more sensitive marker for the reactive astrocytes induced
by ischemia/reperfusion and chemical hypoxia in vitro, and suggested
that the increased expression of bystin might be one of the common
characteristics of astrogliosis.
Fig. 1. Effects of ischemia/reperfusion on the viability of astrocytes. The astrocytes in
Hank's medium without glucose and serum (oxygen–glucose deprivation, ischemic
cells) were exposed to 1% O2 for 0, 0.5, 3, 6, 9, 12, 18 or 24 h and subsequently to 21% O2
(normoxia) for 24 h. The cell viabilities were then measured using an MTT assay as
described in ‘Materials and Methods’. Data are means±SEM (n=18). ⁎⁎pb0.01 vs. the
control.
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2.1. Materials
Unless otherwise stated, all chemicals were obtained from Sigma
Chemical Company, St. Louis, MO, USA. The astrocyte marker glial
ﬁbrillary acidic protein (GFAP) was purchased from Chemicon
International Ltd, UK and the mouse anti-bystin antibody was a
gift from Jiawei Zhou, Shanghai Institutes for Biological Sciences,
China. Fetal bovine serum was obtained from Hyclone, Logan, UT,
USA and Dulbecco's modiﬁed Eagle's medium from Gibco-BRL,
Carlsbad, California, USA. The DC Protein Assay kit was bought from
Bio-Rad Laboratories, Hercules, CA, USA and horseradish (HRP)-
conjugated secondary antibodies from Pierce Chemical Company,
USA.
2.2. Primary culture of mouse cerebrocortical astrocytes
All experiments were carried out with mouse cerebrocortical
astrocytes. The cells were prepared from newborn ICR mice by a
procedure described previously [10,11]. Brieﬂy, cerebral cortices were
cut into small cubes (b1 mm3) and digested with 0.25% trypsin
(Sigma, USA) for 30 min at 37°C. Trypsinization was terminated by an
addition of Dulbecco's modiﬁed Eagle's medium (Gibco, USA) contain-
ing 10% fetal bovine serum (Hyclone, Logan, UT, USA), followed by
mechanical trituration with a ﬂame-polished Pasteur glass pipette.
Cell suspensions were sieved through a 40 μm cell strainer and the
ﬁltrate was allowed pre-adherence for 30 min to remove any
contamination from ﬁbroblast before being seeded at a density of
approximately one cerebrum per 50 cm2 ﬂask (Corning, USA) or six-
well plates (NUNC, Denmark). The plated cells were incubated in a 5%
CO2 incubator at 37 °C. After the cultures reached conﬂuence (12–
14 days), they were subcultured 3 times every 4 days, and were
allowed pre-adherence for 30 min before being seeded in each
subculture. The purity of the astrocytes cultures was assessed by
staining for the astrocyte marker glial ﬁbrillary acidic protein (GFAP)
(Chemicon International Ltd, UK), which was approximately 99%. They
were cultured for another 7 days after the last subculture before being
used.
2.3. Experimental design
To determine the effects of ischemia/reperfusion on cell viabilities
and the expression of bystin and GFAP, the astrocytes in Hank's
medium without glucose and serum (oxygen–glucose deprivation,
ischemic cells) were exposed to 1% O2 in a dedicated incubator
(NAPCO 7101FC-1) with 94% N2 and 5% CO2 at 37 °C for 0, 0.5, 3, 6, 9,
12, 18 or 24 h, and then exposed to 21% O2 (normoxia) for 24 h [12]. To
investigate the effects of chemical hypoxia on cell viabilities and the
expression of bystin and GFAP, the cells were treated with CoCl2 (0,
0.5, 1, 2.5 or 5 mM) for 24 h, or NaN3 (0, 1 or 10 mM) for 15, 30 or
60 min respectively. Then the relevant measurements were
conducted.
2.4. Assessment of cell viability
The cell viabilities of astrocytes that received different treatments
were measured using an MTT (3-(4,5-dimethylthazol-2-yl)-2,5-
diphenyltetrazolinum bromide) assay as described by He et al [13].
Brieﬂy, a total of 25 μL MTT (1 g/L in PBS) was added to each well
before the conduction of incubation at 37 °C for 4 h. The assay was
stopped by the addition of a 100 μL lysis buffer (20% SDS in 50% N'N-
dimethylformamide, pH 4.7). Optical density (OD) was measured at
the 570 nm wavelength by the use of an ELX-800 microplate assay
reader (Bio-tek, USA) and the results were expressed as a percentage
of absorbance measured in the control cells.2.5. Western blot analysis
Astrocytes receiving different treatments were washed with ice-
cold PBS and the proteins were extracted with 150 μl lysis buffer
containing 50 mM Tris–HCl, 150 mM NaCl, 0.5% Igepal, 0.1% sodium
dodecyl sulfate (SDS),10 μg/ml phenylmethysulfonyl ﬂuoride,10 μg/ml
leupeptin, 10 μg/ml pepstatin and 10 μg/ml of heat activated sodium
ortovanadate. After centrifugation at 10,000 ×g for 15 min at 4 °C, the
supernatant was collected. Protein content was determined using the
DC Protein Assay kit (Bio-Rad, Hercules, CA). A total of 30mcg proteins
was boiled in protein loading buffer for 5 min, separated on a 10% SDS-
polyacrylamide gels, and subsequently transferred to nitrocellulose
membranes. Nonspeciﬁc binding was inhibited by incubation in TBST
[20 mM Tris-buffered saline (pH 7.5) with 0.1% Tween 20] containing
5% nonfat dried milk for 2 h at room temperature. The membranes
were incubated with monoclonal antibodies against GFAP and bystin
(1:10000 in TBST containing 5% milk) overnight at 4°C. After three
washes with TBST, the membranes were incubated for 2 h with
horseradish (HRP)-conjugated secondary antibodies (Pierce Chemical
Company, USA) and developed using enhanced chemiluminescence
(ECL western blotting analysis system kit, Amersham Biosciences,
England). The blot was detected using Kodak XAR-5 ﬁlm for
autoradiography. To ensure even loading of the samples, the same
membrane was probed with anti-mouse β-actin monoclonal antibody
(Sigma-Aldrich, MO) at a 1:10000 dilution.
2.6. Statistical analysis
The statistical analyses were performed using SPSS 10.0. Data are
presented as mean±SEM. The difference between means was
determined by One-Way ANOVA followed by a Student-Newman-
Keuls test for multiple comparisons. A probability value of pb0.05 was
taken to be statistically signiﬁcant.
3. Results
3.1. Effects of ischemia/reperfusion on the viability and morphology
of astrocytes
The viability of the cultured astrocytes treated with ischemia/
reperfusion was determined using an MTT assay. The MTT assay
results, as shown in Fig. 1, indicated that the treatment of the cells
Fig. 2. Effects of ischemia/reperfusion on the morphology of astrocytes. The astrocytes in Hank's medium without glucose and serum (oxygen–glucose deprivation, ischemic cells)
were exposed to 1% O2 for 0, 0.5, 3 or 24 h and subsequently to 21% O2 (normoxia) for 24 h. The morphological changes were then observed under a light microscope. (A) the Control;
(B) 0.5 h ischemia; (C) 3 h ischemia; and (D) 24 h ischemia (scale bar=40 mM).
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increase in cell viabilities (pb0.01, vs. the control). No signiﬁcant
difference in cell viabilities was found between the controls and the
cells treated with 6, 9, 12 or 18 h ischemia and 24 h reperfusion.
However, cell viabilities were signiﬁcantly decreased in the cells
treated with 24 h ischemia and 24 h reperfusion (pb0.01, vs. the
control).
In agreement with the results of cell viability, the treatment of the
astrocytes with 0.5 (Fig. 2B) or 3 h (Fig. 2C) ischemia and 24 h
reperfusion induced a characteristic ‘reactive’ morphology, ie. hyper-
trophic processes and stellate-shaped cell bodies. Treatment with 24 h
(Fig. 2D) ischemia and 24 h reperfusion also induced a signiﬁcant
change in cell morphology. Cell bodies began to shrink and processes
decurtated or even disappeared. Relics of the dead cells could be found
under a light microscope (Fig. 2D).Fig. 3. Total protein amount of astrocytes treated with ischemia/reperfusion. The
astrocytes in Hank's mediumwithout glucose and serum (oxygen–glucose deprivation,
ischemic cells) were exposed to 1% O2 for 0, 0.5, 3 or 24 h and subsequently to 21% O2
(normoxia) for 24 h. Total protein amount of astrocytes was then determined using the
DC Protein Assay kit as described in ‘Materials and Methods’. Data are means±SEM
(n=6). ⁎pb0.05, ⁎⁎pb0.01 vs. the control.3.2. Total protein amount of astrocytes treated with ischemia/reperfusion
We then measured the total protein amount of astrocytes treated
with 0.5, 3 or 24 h ischemia and 24 h reperfusion. The results (Fig. 3)
showed that the total protein amount in the cells treated with 0.5 orFig. 4. Effects of ischemia/reperfusion on expression of GFAP and bystin. The astrocytes
in Hank's medium without glucose and serum (oxygen–glucose deprivation, ischemic
cells) were exposed to 1% O2 for 0, 3 or 24 h and subsequently to 21% O2 (normoxia) for
24 h. Western blot analysis were then conducted as described in ‘Materials and
Methods’. (A) A representative experiment of Western blot of bystin, GFAP and β-actin.
(B) Quantiﬁcation of expression of bystin, GFAP proteins in astrocytes. Expression values
were normalized for β-actin and the data were presented as Mean±SEM (n=5).
⁎⁎pb0.01 versus the control (bystin).
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0.01, vs. the control) and in the cells treated with 24 h ischemia and
24 h reperfusion was signiﬁcantly lower (pb0.05, vs. the control)
than that in the control.
3.3. Effects of ischemia/reperfusion on expression of GFAP and bystin
To determine the effects of ischemia/reperfusion on the expres-
sion of bystin and GFAP, the astrocytes in Hank's medium without
glucose and serum were exposed to 1% O2 at 37 °C for 0, 0.5, 3 or
24 h, and then to 21% O2 for 24 h. Western blot results showed that
ischemia/reperfusion did not induce any signiﬁcant changes in the
expression of GFAP (Fig. 4). There were no signiﬁcant differences in
the levels of GFAP in the cells treated with ischemia for 0, 0.5, 3 or
24 h. However, treatment of the cells with ischemia for 0.5 and for
3 h induced a signiﬁcant increase in the expression of bystin (pb0.01,
vs. the control). No difference was found in the expression of bystin
between the cells treated with or without 24 h ischemia and 24 h
reperfusion.Fig. 5. Effects of NaN3 on cell viability and expression of GFAP and bystin in astrocytes. The as
cell viabilities and the expression of proteins were then measured using an MTT assay and W
were presented as Mean±SEM (n=5). ⁎pb0.05, ⁎⁎pb0.01, ⁎⁎⁎pb0.001 versus the control);
Quantiﬁcation of expression of bystin and GFAP proteins in astrocytes. Expression values we
⁎⁎pb0.01, ⁎⁎⁎pb0.001 versus the control (bystin).3.4. Effects of chemical hypoxia on cell viability and the expression of
GFAP and bystin in astrocytes
We subsequently investigated the effects of chemical hypoxia on
cell viability and expression of GFAPandbystin in astrocytes by treating
the cells with 1mMNaN3 for 0,15, 30 or 60min, and 10mM for 60min,
and CoCl2 (0, 0.5, 1, 2.5 or 5 mM) for 24 h, respectively. The MTT assay
results indicated that treatment of the cells with lower concentrations
of NaN3 (1mM) (Fig. 5A) or CoCl2 (0, 0.5,1 or 2.5mM) (Fig. 6A) induced
a signiﬁcant increase in cell viabilities (pb0.05 or 0.01, vs. the control).
However, cell viabilities were signiﬁcantly decreased in the cells
treated with higher concentrations of NaN3 (10 mM) (Fig. 5A) or CoCl2
(5 mM) (Fig. 6A) (pb0.01 or 0.001, vs. the control).
Same as those found in the cells treated with ischemia/reperfusion,
Western blot results showed that treatments of the cells with different
concentrations of NaN3 or CoCl2 did not induce any signiﬁcant effects on
the expression of GFAP (Figs. 5B, C, 6B, C). There were no signiﬁcant
differences in the levels of GFAP in the cells that received different
treatments. However, the expression of bystin was signiﬁcantlytrocytes were treated with 1 mM NaN3 for 0, 15, 30 or 60 min, or 10 mM for 60 min. The
estern blot analysis as described in ‘Materials and Methods’. (A) Cell viability (the data
(B) A representative experiment of Western blot of bystin, GFAP and β-actin; and (C)
re normalized for β-actin and the data were presented as Mean±SEM (n=5). ⁎pb0.05,
Fig. 6. Effects of CoCl2 on cell viability and expression of GFAP and bystin in astrocytes.
The astrocytes were treated with CoCl2 (0, 0.5, 1, 2.5 or 5 mM) for 24 h. The cell
viabilities and the expression of proteins were then measured using an MTT assay and
Western blot analysis as described in ‘Materials andMethods’. (A) Cell viability (the data
were presented as Mean±SEM (n=5). ⁎pb0.05, ⁎⁎pb0.01 versus the control); (B) A
representative experiment of Western blot of bystin, GFAP and β-actin; and (C)
Quantiﬁcation of expression of bystin and GFAP proteins in astrocytes. Expression
values were normalized for β-actin and the data were presented as Mean±SEM (n=5).
⁎⁎pb0.01 versus the control (bystin).
Fig. 7. A hypothetical scheme for the effects of ischemia and hypoxia on astrocytes.
Reactive astrocytes can be induced bymild ischemia and hypoxiawith a remarkable up-
regulation of cell viabilities and increased expression of bystin. Severe ischemia and
hypoxia will result in astrocyte death with a down-regulation of cell viabilities and
bystin expression.
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(Fig. 5B, C) or CoCl2 (0, 0.5,1 or 2.5 mM) (Fig. 6B, C) and decreased in the
cells treated with higher concentrations of NaN3 (10 mM) or CoCl2
(5 mM).
4. Discussion
In the present study, we demonstrated that treatment of themouse
cerebrocortical astrocytes with mild ischemia (1% O2 for 0.5 or 3 h)
could induce a signiﬁcant increase in cell viability, total protein amount
and a characteristic ‘reactive’morphology (hypertrophic processes and
stellate-shaped cell bodies). Similar results were also found in the cells
treatedwithmild chemical hypoxia (1mMof NaN3 for 0,15, 30, 60min
or 0.5, 1, 2.5 mM of CoCl2 for 24 h). These ﬁndings clearly showed that
mild ischemia and hypoxia could activate astrocytes under our
experimental conditions. Our study also demonstrated that the
activated astrocytes or reactive astrocytes have a signiﬁcantly
increased expression of bystin (Fig. 7). Compared with the effects of
ischemia and hypoxia on the expression of GFAP, bystin is amuchmoresensitive marker for reactive astrocytes induced by ischemia and
chemical hypoxia in vitro. The data suggested that bystin might be a
useful marker for stroke and a key factor in the formation of reactive
astrocytes in the brain under ischemia and hypoxia.
To our knowledge, this report is the ﬁrst study on the effects of
ischemia/reperfusion and chemical hypoxia on the expression of
bystin and GFAP in astrocytes. Our ﬁndings demonstrated that the
response of GFAP is much less sensitive than that of bystin to ischemia
and chemical hypoxia in vitro. Western blot results demonstrated that
ischemia did not induce any signiﬁcant changes in the expression of
GFAP. There were no signiﬁcant differences in the levels of GFAP in the
cells treated with ischemia for 0, 0.5, 3 or 24 h. GFAP is a major type of
intermediate ﬁlament (IF). A signiﬁcant increase in GFAP is almost
universally recognized as a marker of astrogliosis [14]. Norton et al [9]
have suggested that different types of injury induce different astrocyte
responses, characterized in terms of the time course, the involvement
of the contralateral side, and whether GFAP mRNA and/or protein are
increased. The different types of injury used in the present study and
others [4,5,8,15,16] might be one of the major reasons for the
differences in results on the changes in the expression of GFAP.
In contrast to GFAP, our data demonstrated that treatment of the
cells with ischemia for 0.5 and for 3 h induced a signiﬁcant increase in
the expression of bystin. Similar results were also found in the cells
treated with mild chemical hypoxia. Human bystin is a 306-amino
acid cytoplasmic protein which mediates a unique homophilic cell
adhesion between trophoblast and endometrial epithelial cells at their
respective apical cell surfaces [6,7,17]. Recent studies suggested that
this protein may play multiple roles in mammalian cells. A function is
to facilitate ribosome biogenesis required for cell growth [18]. It has
also been suggested that bystin expressed by reactive astrocytes may
be involved in their differentiation during the inﬂammatory processes
following brain injury induced by both 6-hydrodopamine-lesioned rat
nigrostriatum and stab-lesioned cerebral cortex in adult rats [8]. In
addition, a potential connection between bystin expression and adult
neurogenesis has also been reported [17,19]. The signiﬁcant and
sensitive response of bystin expression to ischemia and chemical
hypoxia found in the present study strongly suggests that bystin may
play an important role in the changes in astrocytes which lead to
astrogliosis and also in the neuroprotective role of hypoxic and
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vestigate the associated mechanisms, further studies are needed.
The mouse cerebrocortical astrocytes were prepared using the
subculturemethod in the present study.Meanwhile, we noted that in a
number of studies astrocyteswere prepared by amethod that involved
a ‘shaken’ procedure (shaken over night once or twice) in order to
remove microglia and oligodentrocytes [20–26]. We therefore com-
pared the cell viabilities and immunocytochemical staining of GFAP in
‘shaken’ astrocytes with those in subcultured astrocytes. The ﬁndings
showed that these two parameters in the former were signiﬁcantly
higher than in the latter (data not shown). This implies that shaking
itself might activate astrocytes (reactive astrocytes), whereas astro-
cytes prepared by the subculture method are still in an “inactive state”
(quiescent astrocytes). We then measured the effects of ischemia on
cell viabilities in the ‘shaken’ astrocytes and found that there was
no signiﬁcant difference in cell viabilities between the ‘shaken’ cells
treated with or without mild ischemia (1% O2 for 0.5 or 3 h) (data not
shown). It is completely different from that we found in subcultured
cells where cell viability was signiﬁcantly increased by mild ischemia.
These data imply that mild ischemia could induce an increase in cell
viabilities only in ‘quiescent astrocytes’ but not in ‘reactive astrocytes’.
Themild ischemia cannot induce a further increase in cell viabilities in
‘reactive astrocytes’. In addition to the ‘shaken’ procedure, it has
been reported that a serum-free condition could be an incentive to
astrocytes [27], inducing activation of astrocytes. Therefore, it is
possible that mild ischemia might not induce an increase in cell
viabilities in the astrocytes pretreated with serum-free media.
In summary, our data demonstrated for the ﬁrst time that mild
ischemia and chemical hypoxia could activate mouse cerebrocortical
astrocytes and that bystin is amuchmore sensitivemarker in activated
astrocytes induced by ischemia and chemical hypoxia as compared
with GFAP. The signiﬁcant and sensitive response of bystin expression
to ischemia and chemical hypoxia suggests that bystin may play an
important role in the activation of astrocytes as well as in the
neuroprotective role of hypoxic and ischemic preconditioning.
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